Document Detail

Conventional surgery, sutureless valves, and transapical aortic valve replacement: What is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
MedLine Citation:
PMID:  24021955     Owner:  NLM     Status:  Publisher    
OBJECTIVE: Although surgical aortic valve replacement (SAVR) is the treatment of choice for patients with aortic valve stenosis, transcatheter aortic valve replacement (TAVR) and sutureless aortic valve replacement (SU-AVR) have shown good results. The aim of our multicenter, propensity-matched study was to compare the clinical and hemodynamic outcomes of surgical SAVR, transapical TAVR (TA-TAVR), and SU-AVR.
METHODS: We analyzed data from 566 TA-TAVR, 349 SAVR, and 38 SU-AVR patients treated from January 2009 to March 2012. We used a propensity-matching strategy to compare on-pump (SAVR, SU-AVR) and off-pump (TA-TAVR) surgical techniques. The outcomes were analyzed using multivariate weighted logistic regression or multinomial logistic analysis.
RESULTS: In the matched cohorts, the 30-day overall mortality was significantly lower after SAVR than TA-TAVR (7% vs 1.8%, P = .026), with no differences in mortality between SU-AVR and TA-TAVR. Multivariate analysis showed SU-AVR to have a protective effect, although not statistically significant, against aortic regurgitation, pacemaker implantation, and renal replacement therapy compared with TA-TAVR. Compared with TA-TAVR, SAVR demonstrated significant protection against aortic regurgitation (odds ratio, 0.04; P < .001) and a trend toward protection against death, pacemaker implantation, and myocardial infarction. The mean transaortic gradient was 10.3 ± 4.4 mm Hg, 11 ± 3.4 mm Hg, and 16.5 ± 5.8 mm Hg in the TA-TAVR, SU-AVR, and SAVR patients, respectively.
CONCLUSIONS: SAVR was associated with lower 30-day mortality than TA-TAVR. SAVR was also associated with a lower risk of postoperative aortic regurgitation compared with TA-TAVR. We did not find other significant differences in outcomes among matched patients treated with SAVR, SU-AVR, and TA-TAVR.
Augusto D'Onofrio; Giulio Rizzoli; Antonio Messina; Ottavio Alfieri; Roberto Lorusso; Stefano Salizzoni; Mattia Glauber; Roberto Di Bartolomeo; Laura Besola; Mauro Rinaldi; Giovanni Troise; Gino Gerosa
Related Documents :
23710685 - Diminished aortic excursion in chronic thromboembolic pulmonary hypertension.
23602055 - Feasibility of aortic valve assessment with low dose prospectively triggered adaptive s...
23220995 - Congenital atresia of the left main coronary artery in an adult: an extremely rare anom...
23580115 - Permanent cortical blindness after bronchial artery embolization.
23536645 - Salvage of distal non-target coil embolization with stent placement and intravenous ept...
9819785 - The effect of hormone replacement therapy on carotid arteries: measurement with a high ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-7
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  -     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-9-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Division of Cardiac Surgery, University of Padova, Padova, Italy. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor fo...
Next Document:  Correction factors for source strength determination in HDR brachytherapy using the in-phantom metho...